MSD exercises its option on vaccine candidate EVX-B3 for a cash payment of $7.5 million, which extend Evaxion’s cash runway to first half of 2027 MSD will assume full responsibility for the further ...
Merck & Co (MSD) has joined fellow big pharma companies in looking to redirect cash, as the drugmaker revealed plans to save $3bn annually by the end of 2027. Announcing the initiative in its Q2 ...
Louisville MSD will implement a 3.9% rate increase starting Sept. 1, adding $3.11 to the average residential bill. The increase will fund wastewater treatment, stormwater management, flood protection ...
COPENHAGEN - Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has entered into an option and license agreement with pharmaceutical giant MSD, known as Merck & Co., Inc. in the U.S ...
The company will expand its production facilities in Carlow and Cork to meet increased global demand for its medicines and vaccines produced in Ireland. MSD, known as Merck in the US and Canada, ...
A new 20,000-L microbial biologics facility in Ireland will be operational by 2018 for Fujifilm Diosynth's contract development and manufacturing customers. CDMO Fujifilm Diosynth Biotechnologies is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback